MY
Mymetics Corporation
MYMX · OTC
$0.00 +0.00% (+$0.00)
Market Cap 39.0 €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 69.99%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 160,167.00%
Op. margin 58,166.70%
FCF margin 56,300.00%
Quality
0 /100
Poor ROA 65.63%
Asset turnover 0.00x
ROIC 24.57%
Debt
50 /100
Moderate Int. coverage -0.72x
Net debt/EBITDA -36.02x
Current ratio 0.01x
Stability
1 /100
Unstable Rev. volatility 47.56%
EPS volatility 98,194.22%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o MYMX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald Kempers
Employees
2
Headquarters
Epalinges